ABFO NorCal: Navigating the Life Science Liquidity Landscape
Category
Northern California
Registration Info
Registration has closed - Event is past
About this event
As IPO activity continues to heat up in 2026, the pathways to liquidity have become a critical focal point for biotech leaders. For CFOs, founders, and finance executives, the challenge now lies in balancing long-term strategic positioning with the immediate demands of capital markets and evolving FDA regulatory milestones.
ABFO and Connor Group invite you to a candid discussion on these complex liquidity pathways—covering everything from investment banking and licensing deals to the nuances of M&A. Join us for an evening of actionable insights on how to maintain leverage and optionality in a market that is moving faster than ever.
Date: Thursday, April 23
Time: 5:15 PM – 7:30 PM
Location: Rise Woodfire Pizza, San Mateo, CA
Key Discussion Points:
- 2026 IPO Outlook: Assessing market windows and strategic readiness.
- M&A and Licensing: Strategic positioning for acquisition.
- The FDA Variable: Aligning clinical milestones with liquidity.
Ravi Kumar
Partner, Connor Group
Michael Kingston
Managing Director, Lazard
Sujal Shah
President & CEO, Cymabay
Event Information:
This event is for Active and Prospective Members of the NorCal Chapter. If you have not renewed your membership, please log in to process your renewal. If you are not a currently active member of ABFO, please visit the NorCal Chapter page to learn more and join.
This event is limited to accounting and finance life science industry professionals at the director level and above. Vendors, including employees of advisory and recruiting firms, are not permitted to attend without a sponsorship agreement.
Invalid Quantity